Literature DB >> 21458665

Mapping cancer origins.

Richard J Gilbertson1.   

Abstract

Cancer comprises a bewildering assortment of diseases that kill 7.5 million people each year. Poor understanding of cancer's diversity currently thwarts our goal of a cure for every patient, but recent integration of genomic and stem cell technologies promises a route through this impasse.
Copyright © 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh：

Year:  2011        PMID： 21458665      PMCID： PMC3077217          DOI： 10.1016/j.cell.2011.03.019

Source DB:  PubMed          Journal:  Cell        ISSN： 0092-8674            Impact factor:   41.582


  21 in total

1.  Notch signaling regulates mammary stem cell function and luminal cell-fate commitment.

Authors:  Toula Bouras; Bhupinder Pal; François Vaillant; Gwyndolen Harburg; Marie-Liesse Asselin-Labat; Samantha R Oakes; Geoffrey J Lindeman; Jane E Visvader
Journal:  Cell Stem Cell       Date:  2008-10-09       Impact factor: 24.633

2.  BCR-ABL enhances differentiation of long-term repopulating hematopoietic stem cells.

Authors:  Mirle Schemionek; Christian Elling; Ulrich Steidl; Nicole Bäumer; Ashley Hamilton; Tilmann Spieker; Joachim R Göthert; Martin Stehling; Amy Wagers; Claudia S Huettner; Daniel G Tenen; Lara Tickenbrock; Wolfgang E Berdel; Hubert Serve; Tessa L Holyoake; Carsten Müller-Tidow; Steffen Koschmieder
Journal:  Blood       Date:  2010-01-06       Impact factor: 22.113

3.  MOZ-TIF2, but not BCR-ABL, confers properties of leukemic stem cells to committed murine hematopoietic progenitors.

Authors:  Brian J P Huntly; Hirokazu Shigematsu; Kenji Deguchi; Benjamin H Lee; Shinichi Mizuno; Nicky Duclos; Rebecca Rowan; Sonia Amaral; David Curley; Ifor R Williams; Koichi Akashi; D Gary Gilliland
Journal:  Cancer Cell       Date:  2004-12       Impact factor: 31.743

4.  Radial glia cells are candidate stem cells of ependymoma.

Authors:  Michael D Taylor; Helen Poppleton; Christine Fuller; Xiaoping Su; Yongxing Liu; Patricia Jensen; Susan Magdaleno; James Dalton; Christopher Calabrese; Julian Board; Tobey Macdonald; Jim Rutka; Abhijit Guha; Amar Gajjar; Tom Curran; Richard J Gilbertson
Journal:  Cancer Cell       Date:  2005-10       Impact factor: 31.743

5.  Transformation from committed progenitor to leukaemia stem cell initiated by MLL-AF9.

Authors:  Andrei V Krivtsov; David Twomey; Zhaohui Feng; Matthew C Stubbs; Yingzi Wang; Joerg Faber; Jason E Levine; Jing Wang; William C Hahn; D Gary Gilliland; Todd R Golub; Scott A Armstrong
Journal:  Nature       Date:  2006-07-16       Impact factor: 49.962

6.  Breast cancer classification and prognosis based on gene expression profiles from a population-based study.

Authors:  Christos Sotiriou; Soek-Ying Neo; Lisa M McShane; Edward L Korn; Philip M Long; Amir Jazaeri; Philippe Martiat; Steve B Fox; Adrian L Harris; Edison T Liu
Journal:  Proc Natl Acad Sci U S A       Date:  2003-08-13       Impact factor: 11.205

7.  Gene expression profiling of pediatric acute myelogenous leukemia.

Authors:  Mary E Ross; Rami Mahfouz; Mihaela Onciu; Hsi-Che Liu; Xiaodong Zhou; Guangchun Song; Sheila A Shurtleff; Stanley Pounds; Cheng Cheng; Jing Ma; Raul C Ribeiro; Jeffrey E Rubnitz; Kevin Girtman; W Kent Williams; Susana C Raimondi; Der-Cherng Liang; Lee-Yung Shih; Ching-Hon Pui; James R Downing
Journal:  Blood       Date:  2004-06-29       Impact factor: 22.113

8.  BRCA1 basal-like breast cancers originate from luminal epithelial progenitors and not from basal stem cells.

Authors:  Gemma Molyneux; Felipe C Geyer; Fiona-Ann Magnay; Afshan McCarthy; Howard Kendrick; Rachael Natrajan; Alan Mackay; Anita Grigoriadis; Andrew Tutt; Alan Ashworth; Jorge S Reis-Filho; Matthew J Smalley
Journal:  Cell Stem Cell       Date:  2010-09-03       Impact factor: 24.633

9.  Comprehensive genomic characterization defines human glioblastoma genes and core pathways.

Authors: 
Journal:  Nature       Date:  2008-09-04       Impact factor: 49.962

10.  Acquisition of granule neuron precursor identity is a critical determinant of progenitor cell competence to form Shh-induced medulloblastoma.

Authors:  Ulrich Schüller; Vivi M Heine; Junhao Mao; Alvin T Kho; Allison K Dillon; Young-Goo Han; Emmanuelle Huillard; Tao Sun; Azra H Ligon; Ying Qian; Qiufu Ma; Arturo Alvarez-Buylla; Andrew P McMahon; David H Rowitch; Keith L Ligon
Journal:  Cancer Cell       Date:  2008-08-12       Impact factor: 31.743
View more
  16 in total

Review 1.  The choroid plexus and cerebrospinal fluid: emerging roles in development, disease, and therapy.

Authors:  Maria K Lehtinen; Christopher S Bjornsson; Susan M Dymecki; Richard J Gilbertson; David M Holtzman; Edwin S Monuki
Journal:  J Neurosci       Date:  2013-11-06       Impact factor: 6.167

2.  Establishing a Preclinical Multidisciplinary Board for Brain Tumors.

Authors:  Birgit V Nimmervoll; Nidal Boulos; Brandon Bianski; Jason Dapper; Michael DeCuypere; Anang Shelat; Sabrina Terranova; Hope E Terhune; Amar Gajjar; Yogesh T Patel; Burgess B Freeman; Arzu Onar-Thomas; Clinton F Stewart; Martine F Roussel; R Kipling Guy; Thomas E Merchant; Christopher Calabrese; Karen D Wright; Richard J Gilbertson
Journal:  Clin Cancer Res       Date:  2018-01-04       Impact factor: 12.531

Review 3.  Context-dependent actions of Polycomb repressors in cancer.

Authors:  M Koppens; M van Lohuizen
Journal:  Oncogene       Date:  2015-06-08       Impact factor: 9.867

Review 4.  The role of LncRNA LBX2-AS1 in cancers: functions, mechanisms and potential clinical utility.

Authors:  Yuanshuai Su; Chengzhi Li; Yu Fang; Xinyu Gu; Qiuxian Zheng; Juan Lu; Lanjuan Li
Journal:  Clin Transl Oncol       Date:  2022-09-21       Impact factor: 3.340

Review 5.  Multidrug-resistant cancer cells and cancer stem cells hijack cellular systems to circumvent systemic therapies, can natural products reverse this?

Authors:  Qian Zhang; Yunjiang Feng; Derek Kennedy
Journal:  Cell Mol Life Sci       Date:  2016-09-12       Impact factor: 9.261

6.  Identification of Hedgehog pathway responsive glioblastomas by isocitrate dehydrogenase mutation.

Authors:  J Gerardo Valadez; Vandana K Grover; Melissa D Carter; M Wade Calcutt; Sunday A Abiria; Christopher J Lundberg; Thomas V Williams; Michael K Cooper
Journal:  Cancer Lett       Date:  2012-10-11       Impact factor: 8.679

7.  Active medulloblastoma enhancers reveal subgroup-specific cellular origins.

Authors:  Charles Y Lin; Serap Erkek; Yiai Tong; Linlin Yin; Alexander J Federation; Marc Zapatka; Parthiv Haldipur; Daisuke Kawauchi; Thomas Risch; Hans-Jörg Warnatz; Barbara C Worst; Bensheng Ju; Brent A Orr; Rhamy Zeid; Donald R Polaski; Maia Segura-Wang; Sebastian M Waszak; David T W Jones; Marcel Kool; Volker Hovestadt; Ivo Buchhalter; Laura Sieber; Pascal Johann; Lukas Chavez; Stefan Gröschel; Marina Ryzhova; Andrey Korshunov; Wenbiao Chen; Victor V Chizhikov; Kathleen J Millen; Vyacheslav Amstislavskiy; Hans Lehrach; Marie-Laure Yaspo; Roland Eils; Peter Lichter; Jan O Korbel; Stefan M Pfister; James E Bradner; Paul A Northcott
Journal:  Nature       Date:  2016-01-27       Impact factor: 49.962

Review 8.  Medulloblastomics: the end of the beginning.

Authors:  Paul A Northcott; David T W Jones; Marcel Kool; Giles W Robinson; Richard J Gilbertson; Yoon-Jae Cho; Scott L Pomeroy; Andrey Korshunov; Peter Lichter; Michael D Taylor; Stefan M Pfister
Journal:  Nat Rev Cancer       Date:  2012-12       Impact factor: 60.716

Review 9.  Molecular subgroups of medulloblastoma.

Authors:  Paul A Northcott; Adrian M Dubuc; Stefan Pfister; Michael D Taylor
Journal:  Expert Rev Neurother       Date:  2012-07       Impact factor: 4.618

10.  On the origin of glioma.

Authors:  Yiwen Jiang; Lene Uhrbom
Journal:  Ups J Med Sci       Date:  2012-02-21       Impact factor: 2.384
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.